Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.18B |
| 2 |
Medtronic
MDT
|
+$2.06B |
| 3 |
Microsoft
MSFT
|
+$1.61B |
| 4 |
Procter & Gamble
PG
|
+$1.47B |
| 5 |
UBS Group
UBS
|
+$1.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.42B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$2.34B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$930M |
| 4 |
Apple
AAPL
|
+$637M |
| 5 |
SWY
SAFEWAY INC
SWY
|
+$620M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.67% |
| 2 | Technology | 13.6% |
| 3 | Financials | 13.57% |
| 4 | Industrials | 10.71% |
| 5 | Consumer Discretionary | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXIA
3226
AXIA Energia
AXIA
$23.3B
| $3.04M | ﹤0.01% |
2,185,620
| – | – |
|
|
AVEO
3227
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $3.03M | ﹤0.01% |
208,848
+25,746
| +14% | +$281K |
|
|
AVG
3228
DELISTED
AVG Technologies N.V.
AVG
| $3.02M | ﹤0.01% |
139,562
-237,069
| -63% | -$4.99M |
|
|
STS
3229
DELISTED
Supreme Industries Inc Class A
STS
| $3.02M | ﹤0.01% |
385,432
+5,390
| +1% | +$42.8K |
|
3230
Energy Recovery
ERII
$450M
| $3.02M | ﹤0.01% |
1,164,553
+14,849
| +1% | +$51K |
|
|
RBCN
3231
DELISTED
Rubicon Technology, Inc.
RBCN
| $3.02M | ﹤0.01% |
76,533
+3,624
| +5% | +$154K |
|
|
BIOL
3232
DELISTED
Biolase, Inc.
BIOL
| $3M | ﹤0.01% |
119
+2
| +2% | +$56.7K |
|
3233
Ituran Location and Control
ITRN
$1.08B
| $3M | ﹤0.01% |
+136,291
| New | +$3.01M |
|
|
HGG
3234
DELISTED
hhgregg Inc.
HGG
| $2.99M | ﹤0.01% |
488,163
+3,256
| +0.7% | +$19.9K |
|
3235
Willdan Group
WLDN
$1.11B
| $2.99M | ﹤0.01% |
188,687
+29,895
| +19% | +$412K |
|
|
MBLY
3236
DELISTED
Mobileye N.V.
MBLY
| $2.98M | ﹤0.01% |
71,013
+55,425
| +356% | +$2.16M |
|
|
NTLS
3237
DELISTED
NTELOS HLDGS CORP COM
NTLS
| $2.98M | ﹤0.01% |
621,601
+9,620
| +2% | +$45.3K |
|
|
PCMI
3238
DELISTED
PCM, Inc
PCMI
| $2.97M | ﹤0.01% |
318,380
+1,700
| +0.5% | +$16K |
|
|
ASFI
3239
DELISTED
Asta Funding Inc
ASFI
| $2.97M | ﹤0.01% |
355,950
+1,500
| +0.4% | +$12.7K |
|
|
DCOY
3240
Decoy Therapeutics
DCOY
$2.16M
| – | – |
0
| – | – |
|
3241
Neonode
NEON
$16M
| $2.96M | ﹤0.01% |
93,474
| – | – |
|
|
JASN
3242
DELISTED
Jason Industries, Inc.
JASN
| $2.96M | ﹤0.01% |
418,130
+56,983
| +16% | +$453K |
|
|
VTAE
3243
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $2.96M | ﹤0.01% |
252,772
+125,095
| +98% | +$1.69M |
|
|
SPRT
3244
DELISTED
support.com, Inc.
SPRT
| $2.95M | ﹤0.01% |
630,228
+54,781
| +10% | +$298K |
|
|
EPRS
3245
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
| $2.95M | ﹤0.01% |
329,420
+248,012
| +305% | +$1.99M |
|
3246
Eastern Company
EML
$151M
| $2.95M | ﹤0.01% |
146,933
+4,281
| +3% | +$82.5K |
|
3247
Peraso
PRSO
$10.8M
| $2.94M | ﹤0.01% |
175
+25
| +17% | +$398K |
|
|
XIFR
3248
XPLR Infrastructure LP
XIFR
$1.08B
| $2.92M | ﹤0.01% |
66,752
-1,789
| -3% | -$71.2K |
|
3249
Aware
AWRE
$26.8M
| $2.92M | ﹤0.01% |
662,815
+3,394
| +0.5% | +$15.6K |
|
3250
GSI Technology
GSIT
$254M
| $2.9M | ﹤0.01% |
492,204
+3,300
| +0.7% | +$18.1K |
|
Similar funds
Vanguard Group's Q1 2015 Portfolio in Review
As of Q1 2015, Vanguard Group held 4,228 positions worth $1.47T, up 6.2% from $1.39T the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Vanguard Group deployed $66B of net new capital in Q1 2015, opening 181 new positions and adding to 3,456 existing holdings. Its largest new stake was UBS Group: 57,940,325 shares worth $1.09B.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $637M trimmed.
- Vanguard Group's largest Q1 2015 buy was UBS Group: 57,940,325 shares worth $1.09B.
- Vanguard Group added most to Allergan plc in Q1 2015, an estimated $2.18B increase.
- Vanguard Group's biggest Q1 2015 reduction was Apple, cutting an estimated $637M.
- Vanguard Group fully exited Allergan Inc in Q1 2015, selling an estimated $3.42B.
- Vanguard Group's ten largest holdings make up 12% of its $1.47T portfolio in Q1 2015.
- Vanguard Group opened 181 new positions and closed 75 in Q1 2015.
- Vanguard Group's portfolio value rose 6.2% quarter-over-quarter to $1.47T.
Based on Vanguard Group's 13F filing for Q1 2015, filed 14 May 2015.